Abstract Library

#1519 Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options

Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Sokolov V, Pirogov S, Karpova E, Pavlov P, Sokolov D,

Keywords: gastric, NET, endoscopic, EMR, ESD, APC,

#1205 Temozolomid-Based Therapy in GEP-and Bronchopulmonary NEN from a Multicentric Study from Germany

Introduction: Chemotherapy (CTx) with temozolomid as mono (TEM) or combination therapy with capcitabine (TEM/CAP) is a new cytotoxic regimen with good efficiency in pancreatic and bronchopulmonary NET-G1/G2 and NEC-G3.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Maasberg S, Bacher M, Rinke A, Lahner H, Unger N,

Keywords: temozolomide, capecitabine,

#763 Endoscopic Therapy with Argon Plasma Coagulation for Multiple Type 1 Gastric Carcinoid Tumors

Introduction: Data regarding Type I gastric carcinoids and their evolution in prospective series are scarce, thus treatment and follow-up are not codified.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Castano R

Authors: Castano R, Vargas C, Pérez J, Muñoz M, Dueñas J,

Keywords: gastric type I neuroendocrine tumors, endoscopy, Argon plasma coagulation,

#471 Alterations of Global and Gene-Specific DNA Methylation in Midgut Carcinoids

Introduction: Epigenetic alterations of DNA methylation are known to be associated with the clinical presentation of midgut carcinoids.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Fotouhi O, Hashemi J, Kjellman M, Höög A, Zedenius J,

Keywords: midgut carcinoid, methylation,